JP2025184979A5 - - Google Patents

Info

Publication number
JP2025184979A5
JP2025184979A5 JP2025162640A JP2025162640A JP2025184979A5 JP 2025184979 A5 JP2025184979 A5 JP 2025184979A5 JP 2025162640 A JP2025162640 A JP 2025162640A JP 2025162640 A JP2025162640 A JP 2025162640A JP 2025184979 A5 JP2025184979 A5 JP 2025184979A5
Authority
JP
Japan
Prior art keywords
amino acid
sequence
polypeptide
vector
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025162640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025184979A (ja
Filing date
Publication date
Priority claimed from GBGB2004826.0A external-priority patent/GB202004826D0/en
Priority claimed from GBGB2010672.0A external-priority patent/GB202010672D0/en
Priority claimed from GBGB2015775.6A external-priority patent/GB202015775D0/en
Priority claimed from GBGB2101824.7A external-priority patent/GB202101824D0/en
Priority claimed from GBGB2103214.9A external-priority patent/GB202103214D0/en
Priority claimed from PCT/GB2021/050830 external-priority patent/WO2021198706A2/en
Application filed filed Critical
Publication of JP2025184979A publication Critical patent/JP2025184979A/ja
Publication of JP2025184979A5 publication Critical patent/JP2025184979A5/ja
Pending legal-status Critical Current

Links

JP2025162640A 2020-04-01 2025-09-29 コロナウイルスワクチン Pending JP2025184979A (ja)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GB2004826.0 2020-04-01
GBGB2004826.0A GB202004826D0 (en) 2020-04-01 2020-04-01 Coronavirus vaccines
GBGB2010672.0A GB202010672D0 (en) 2020-07-10 2020-07-10 Coronovirus vaccines
GB2010672.0 2020-07-10
GBGB2015775.6A GB202015775D0 (en) 2020-10-05 2020-10-05 Coronavirus vaccines
GB2015775.6 2020-10-05
GB2101824.7 2021-02-10
GBGB2101824.7A GB202101824D0 (en) 2021-02-10 2021-02-10 Coronavirus vaccines
GB2103214.9 2021-03-08
GBGB2103214.9A GB202103214D0 (en) 2021-03-08 2021-03-08 Coronavirus vaccines
PCT/GB2021/050830 WO2021198706A2 (en) 2020-04-01 2021-04-01 Coronavirus vaccines
JP2022560285A JP2023522156A (ja) 2020-04-01 2021-04-01 コロナウイルスワクチン

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022560285A Division JP2023522156A (ja) 2020-04-01 2021-04-01 コロナウイルスワクチン

Publications (2)

Publication Number Publication Date
JP2025184979A JP2025184979A (ja) 2025-12-18
JP2025184979A5 true JP2025184979A5 (https=) 2026-04-16

Family

ID=75426636

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022560285A Pending JP2023522156A (ja) 2020-04-01 2021-04-01 コロナウイルスワクチン
JP2025162640A Pending JP2025184979A (ja) 2020-04-01 2025-09-29 コロナウイルスワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022560285A Pending JP2023522156A (ja) 2020-04-01 2021-04-01 コロナウイルスワクチン

Country Status (7)

Country Link
US (1) US20240285751A1 (https=)
EP (1) EP4126033A2 (https=)
JP (2) JP2023522156A (https=)
CN (1) CN116113431A (https=)
AU (1) AU2021249525A1 (https=)
CA (1) CA3179038A1 (https=)
WO (1) WO2021198706A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4103231A4 (en) 2020-02-14 2024-03-27 Geovax, Inc. VACCINES AND THEIR USES TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV2
CN113527444B (zh) * 2020-04-13 2022-12-27 中国科学院微生物研究所 与新型冠状病毒的抗体有效结合的表位
IL297419B2 (en) 2020-04-22 2025-02-01 BioNTech SE Coronavirus vaccine
WO2021249011A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Hiv vaccine compositions, methods, and uses thereof
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
WO2022041760A1 (en) 2020-08-31 2022-03-03 Sichuan Clover Biopharmaceuticals, Inc. Methods and compositions for purification of trimeric fusion proteins
US20240293534A1 (en) * 2021-06-14 2024-09-05 Modernatx, Inc. Coronavirus glycosylation variant vaccines
EP4183409A1 (en) * 2021-11-17 2023-05-24 Charité - Universitätsmedizin Berlin Vaccine with improved immunogenicity against mutant coronaviruses
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
WO2024002985A1 (en) 2022-06-26 2024-01-04 BioNTech SE Coronavirus vaccine
JP2026508394A (ja) 2023-03-03 2026-03-10 ディオシンバックス リミテッド コロナウイルスワクチン
EP4687969A1 (en) * 2023-04-05 2026-02-11 DIOSynVax Ltd Coronavirus vaccines inducing broad immunity against variants
WO2025083402A1 (en) * 2023-10-16 2025-04-24 Diosynvax Ltd Coronavirus vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG128680A1 (en) * 2003-07-22 2007-01-30 Crucell Holland Bv Binding molecules against sars-coronavirus and uses thereof
WO2005077103A2 (en) * 2004-02-12 2005-08-25 Regents Of The University Of Colorado Compositions and methods for modification and prevention of sars coronavirus infectivity
CN1884303A (zh) * 2005-06-20 2006-12-27 中国医学科学院基础医学研究所 SARS－CoV病毒结构蛋白的融合蛋白及其高量表达与纯化和用途
CN102690336A (zh) * 2012-06-11 2012-09-26 中国科学院武汉病毒研究所 蝙蝠sars样冠状病毒刺突蛋白免疫决定区及制备方法和用途
WO2015143335A1 (en) * 2014-03-20 2015-09-24 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
CN106928326B (zh) * 2015-12-31 2019-12-24 中国科学院微生物研究所 一种基于二聚化的受体结合区亚单位的冠状病毒疫苗
WO2019169120A1 (en) * 2018-02-28 2019-09-06 University Of Washington Self-asssembling nanostructure vaccines
US11918643B2 (en) * 2020-12-22 2024-03-05 CureVac SE RNA vaccine against SARS-CoV-2 variants

Similar Documents

Publication Publication Date Title
JP2025184979A5 (https=)
US11229694B2 (en) Vaccine against RSV
US8389275B2 (en) Fusion proteins of HIV regulatory/accessory proteins
JP2023513611A5 (https=)
JP2023512519A5 (https=)
JP2020528743A5 (https=)
CA2461380A1 (en) Hepatitis c virus vaccine
JP2003510050A5 (https=)
JP2020536489A5 (https=)
JP2023522154A5 (https=)
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
JP2025094154A5 (https=)
JP2025508676A5 (https=)
JP2024537250A5 (https=)
JP2005512518A5 (https=)
CN115975053A (zh) 靶向新型冠状病毒的疫苗
RU2019113940A (ru) Мозаичные вакцины от вируса ящура серотипа а
JP2006514606A (ja) 疎水性タンパク質の発現
KR102616012B1 (ko) 당화된 돼지 인터페론-알파를 발현하는 재조합 베큘로바이러스
RU2021128662A (ru) Нуклеиновая кислота и вакцина против коронавируса с её использованием
HK40051815A (en) Vaccine against rsv comprising modified f polypeptide
JP2023111915A5 (https=)
RU2011121850A (ru) Иммуногенные композиции pcv2 и способы получения таких композиций
HK1250939B (en) Vaccine against rsv